Overview

Children with hereditary spherocytosis are treated at Seattle Children's, an SCCA parent organization. Seattle Children's has a long history of successfully caring for children and teens who have blood disorders.

Hereditary spherocytosis is genetic blood disorder that causes the destruction of red blood cells.
 
Hereditary spherocytosis is not very common, so community doctors usually have limited knowledge of the disease. This is why almost all children with hereditary spherocytosis in the United States receive treatment at one of the children’s cancer centers that make up the Children’s Oncology Group (COG) and Seattle Children's is a member of COG.

Children’s blood disorders program brings together experts from more than 20 subspecialties to provide diagnostic services and treatments, including the very latest options. The team of pediatric hematologists, nurse practitioners, physician assistants, nurses, child life specialists and chaplains partner with you to provide expert, family-centered care and compassionate support. We help you understand your child’s health and treatment options because you, your child and your family are an important part of the care team.

Because Children’s doctors take part in national and international research studies, and often lead them, Children’s can offer new treatment options that many other hospitals cannot give their patients.

Read more about hereditary spherocytosis on the Seattle Children’s web site.

To make an appointment, call Seattle Children's at (206) 987-2106.